A New Bevacizumab Carrier for Intravitreal Administration: Focus on Stability

• Main Authors: Daniela Chirio (Author), Elena Peira (Author), Simona Sapino (Author), Giulia Chindamo (Author), Simonetta Oliaro-Bosso (Author), Salvatore Adinolfi (Author), Chiara Dianzani (Author), Francesca Baratta (Author), Marina Gallarate (Author)
• Format: Book
• Published: MDPI AG, 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Bevacizumab (BVZ) is a monoclonal antibody that binds to human vascular endothelial growth factor A (VEGF-A) and inhibits the interaction between VEGF-A and VEGF receptors, thus blocking the angiogenesis. Repeated intravitreal injections of BVZ for the treatment of ocular pathologies that present an...